5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring
Key Takeaways
- Moderate sedation preserves purposeful response to verbal or light tactile stimulus and spontaneous ventilation; withdrawal from pain is not a purposeful response.
- Naloxone is titrated in 0.04-0.08 mg increments, and its 30-90 minute duration is shorter than that of most opioids, so re-sedation surveillance is mandatory.
- Flumazenil reverses benzodiazepines but can precipitate seizures in chronic benzodiazepine users and in mixed tricyclic overdose, so it is used selectively.
- Midazolam and fentanyl given together produce synergistic, not additive, respiratory depression, and doses of both are reduced when combined.
- A modified Aldrete score of 9 or more out of 10 is the conventional threshold for discharge from phase I recovery.
5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring
Nearly every EP procedure is performed under sedation administered and monitored by the procedural team. CCI tests this under task B1 (patient comfort measures, e.g., sedation) and task B3 (recognize pharmacologic effects of medications — mechanism of action, pharmacokinetics), with basic pharmacology and medication administration in the knowledge list.
1. The Sedation Continuum
Sedation is a continuum, not a set of discrete states, and a patient can slide from one level to the next with a single additional dose.
| Minimal (anxiolysis) | Moderate ("conscious") | Deep | General anesthesia | |
|---|---|---|---|---|
| Responsiveness | Normal to verbal | Purposeful to verbal or light tactile | Purposeful only after repeated or painful stimulus | Unarousable even to pain |
| Airway | Unaffected | No intervention required | May require intervention | Often requires intervention |
| Spontaneous ventilation | Unaffected | Adequate | May be inadequate | Frequently inadequate |
| Cardiovascular | Unaffected | Usually maintained | Usually maintained | May be impaired |
Two rules follow directly and are heavily tested. First, reflex withdrawal from a painful stimulus is not a purposeful response — a patient who only withdraws has passed beyond moderate sedation. Second, the practitioner must be qualified to rescue a patient from one level deeper than intended, because the transition is not predictable.
Required monitoring during moderate sedation: continuous ECG, pulse oximetry, capnography, blood pressure at defined intervals, and level of consciousness, all documented at set intervals with a dedicated observer whose primary responsibility is the patient rather than the procedure.
2. The Sedation Agents
| Agent | Class | Onset / duration (IV) | Key properties |
|---|---|---|---|
| Midazolam | Benzodiazepine (GABA-A) | 1-3 min / 30-60 min | Anxiolysis, anterograde amnesia, no analgesia; respiratory depression; reversed by flumazenil |
| Fentanyl | Synthetic opioid (µ receptor) | 1-3 min / 30-60 min | Potent analgesia, minimal histamine release, hemodynamically stable; chest wall rigidity at high rapid doses; reversed by naloxone |
| Morphine | Opioid | 5-10 min / 3-4 h | Histamine release, venodilation, hypotension; renally cleared active metabolite |
| Propofol | Alkylphenol (GABA-A) | 30-60 s / 3-10 min | Rapid on and off, antiemetic, no analgesia, no reversal agent; dose-dependent apnea and hypotension |
| Dexmedetomidine | Central α₂ agonist | 5-10 min after load / 1-2 h | Sedation with preserved respiratory drive; causes bradycardia and hypotension — a real consideration when sinus node function is being tested |
| Ketamine | NMDA antagonist | 30-60 s / 10-20 min | Dissociative; preserves airway reflexes and respiratory drive; sympathomimetic (raises heart rate and blood pressure); emergence phenomena |
| Lidocaine (local) | Amide local anesthetic | 1-2 min / 30-120 min | Max 4.5 mg/kg plain, 7 mg/kg with epinephrine |
Interactions that change practice
- Midazolam plus fentanyl is synergistic, not additive: the combination depresses ventilation far more than either alone, so doses of both are reduced and given in small increments with time to observe effect.
- Propofol has no reversal agent. Every propofol plan is an airway plan.
- Dexmedetomidine's bradycardia can confound sinus node recovery time and AV nodal measurements, and it can produce profound bradycardia in a patient already on beta blockade.
- Deep sedation and general anesthesia suppress arrhythmia inducibility, which is why many diagnostic EP studies are performed under lighter sedation and why isoproterenol may be required after a deeply sedated induction attempt fails.
Local anesthetic systemic toxicity (LAST)
Progression is neurologic before cardiac: circumoral numbness, metallic taste, tinnitus, visual disturbance → agitation and seizures → CNS depression → cardiac conduction slowing, arrhythmia, and arrest. Treatment is airway support, seizure control with a benzodiazepine, avoidance of vasopressin and calcium channel blockers, reduced-dose epinephrine if needed, and 20% lipid emulsion as the specific therapy.
3. Reversal Agents
| Naloxone | Flumazenil | |
|---|---|---|
| Reverses | Opioids | Benzodiazepines |
| Mechanism | Competitive µ-opioid antagonist | Competitive GABA-A benzodiazepine-site antagonist |
| Dose | 0.04-0.08 mg IV increments, repeat every 2-3 min, titrated to ventilation | 0.2 mg IV over 15 s, then 0.2 mg every minute to a usual max of 1 mg |
| Onset | 1-2 min | 1-2 min |
| Duration | 30-90 min | ~45-60 min |
| Key hazard | Abrupt full reversal causes pain, agitation, hypertension, tachycardia, and pulmonary edema | Seizures in chronic benzodiazepine users, benzodiazepine-dependent patients, and mixed tricyclic overdose |
The governing principle for both agents: their duration of action is shorter than that of the drug being reversed, so a patient who responds must be monitored for re-sedation for at least two hours after the last reversal dose.
The correct sequence when a sedated patient becomes apneic is airway first, drug second: open the airway, apply bag-valve-mask ventilation with 100% oxygen, then titrate reversal. Pushing a large bolus of naloxone before supporting ventilation is the classic wrong answer, and giving flumazenil reflexively to a patient on chronic benzodiazepines converts a manageable airway problem into status epilepticus.
4. Assessment Scales
Depth of sedation — Ramsay Sedation Scale
| Level | Description |
|---|---|
| 1 | Anxious, agitated, restless |
| 2 | Cooperative, oriented, tranquil |
| 3 | Responds to commands only |
| 4 | Brisk response to light glabellar tap or loud auditory stimulus |
| 5 | Sluggish response to the same stimulus |
| 6 | No response |
Levels 2-4 correspond broadly to appropriate procedural sedation; levels 5-6 indicate deep sedation or general anesthesia.
The Richmond Agitation-Sedation Scale (RASS) runs from +4 (combative) through 0 (alert and calm) to −5 (unarousable), and is preferred where agitation must also be graded.
Recovery readiness — modified Aldrete score
Five categories, each scored 0-2, for a maximum of 10:
| Category | 2 | 1 | 0 |
|---|---|---|---|
| Activity | Moves 4 extremities | Moves 2 | Moves 0 |
| Respiration | Breathes deeply, coughs freely | Dyspnea, shallow | Apneic |
| Circulation | BP within 20% of baseline | Within 20-50% | Beyond 50% |
| Consciousness | Fully awake | Arousable on calling | Not responding |
| Oxygen saturation | > 92% on room air | Needs O₂ to keep > 90% | < 90% with O₂ |
A score of ≥ 9 is the conventional threshold for discharge from phase I recovery, together with stable vital signs, controlled pain and nausea, an intact access site, and — for the EP patient — a stable rhythm and adequate distal pulses.
5. Pre-Sedation Assessment
ASA physical status classification:
| Class | Description |
|---|---|
| I | Normal healthy patient |
| II | Mild systemic disease |
| III | Severe systemic disease — most EP ablation patients |
| IV | Severe systemic disease that is a constant threat to life |
| V | Moribund, not expected to survive without the operation |
| VI | Declared brain-dead organ donor |
Airway assessment uses the Mallampati classification (I: soft palate, fauces, uvula, pillars visible → IV: soft palate not visible), thyromental distance, mouth opening, neck mobility, dentition, and body habitus. A history of obstructive sleep apnea — common in the atrial fibrillation population — predicts airway obstruction under sedation and is an independent reason to plan for anesthesia support.
Fasting (ASA guidance): clear liquids 2 hours, breast milk 4 hours, light meal / infant formula / non-human milk 6 hours, fried or fatty food and meat 8 hours. Contemporary guidance also addresses GLP-1 receptor agonists, which delay gastric emptying and increase residual gastric content, prompting either a longer fast or a held dose before elective sedation.
During moderate sedation with midazolam and fentanyl, a patient stops responding to verbal commands but withdraws briskly when the femoral site is manipulated, with a respiratory rate of 8 and end-tidal CO2 of 52 mmHg. How should this level of sedation be classified and managed?
A patient who takes clonazepam nightly for years becomes deeply sedated and hypoventilates after receiving midazolam and fentanyl. Bag-valve-mask ventilation restores oxygenation. Why is flumazenil a poor choice here?
A patient recovering after ablation moves all four extremities, breathes deeply and coughs freely, has a blood pressure within 15 percent of baseline, is fully awake, and maintains an oxygen saturation of 94 percent on room air. What is the modified Aldrete score, and what does it indicate?